The BRAIN TRIAL: a randomised, placebo controlled trial of a Bradykinin B2 receptor antagonist (Anatibant) in patients with traumatic brain injury

por Shakur, Haleema, Andrews, Peter, Asser, Toomas, Balica, Laura, Boeriu, Cristian, Quintero, Juan Diego Ciro, Dewan, Yashbir, Druwé, Patrick, Fletcher, Olivia, Frost, Chris, Hartzenberg, Bennie, Mantilla, Jorge Mejia, Murillo-Cabezas, Francisco, Pachl, Jan, Ravi, Ramalingam R, Rätsep, Indrek, Sampaio, Cristina, Singh, Manmohan, Svoboda, Petr, Roberts, Ian
Publicado 2009